Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase (PFK-1)

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 8, 2012, Pages 1198-1206

  Abrantes, Juliana L ^a,b   Alves, Cristiane M ^b   Costa, Jessica ^b   Almeida, Fabio C L ^a   Sola Penna, Mauro ^a   Fontes, Carlos Frederico L ^a   Souza, Thiago Moreno L ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Glycolysis; HSV 1; PFK 1

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID; SERINE; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; ENZYME ACTIVATION; GLUCOSE; GLYCOLYSIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; PHOSPHOFRUCTOKINASE-1; VERO CELLS;

HEPATITIS C VIRUS; HERPES; HUMAN HERPESVIRUS 1;

EID: 84861210635     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.04.011     Document Type: Article

References (69)

1. Waggoner-Fountain L.A., Grossman L.B. Herpes simplex virus. Pediatr. Rev. 2004, 25:86-93.
2. Corey L., Spear P.G. Infections with herpes simplex viruses (1). N. Engl. J. Med. 1986, 314:686-691.
3. Heldwein E.E., Krummenacher C. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 2008, 65:1653-1668.
4. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11307-11312.
5. Whitley R. New approaches to the therapy of HSV infections. Herpes 2006, 13:53-55.
6. Abdel-Haq N., Chearskul P., Al-Tatari H., Asmar B. New antiviral agents. Indian J. Pediatr. 2006, 73:313-321.
7. Sorbara L.R., Maldarelli F., Chamoun G., Schilling B., Chokekijcahi S., Staudt L., Mitsuya H., Simpson I.A., Zeichner S.L. Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression. J. Virol. 1996, 70:7275-7279.
8. Vignoli A.L., Martini I., Haglid K.G., Silvestroni L., Augusti-Tocco G., Biagioni S. Neuronal glycolytic pathway impairment induced by HIV envelope glycoprotein gp120. Mol. Cell. Biochem. 2000, 215:73-80.
9. Piccoli C., Quarato G., Ripoli M., D'Aprile A., Scrima R., Cela O., Boffoli D., Moradpour D., Capitanio N. HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim. Biophys. Acta 2009, 1787:539-546.
10. El-Bacha T., Menezes M.M., Azevedo e Silva M.C., Sola-Penna M., Da Poian A.T. Mayaro virus infection alters glucose metabolism in cultured cells through activation of the enzyme 6-phosphofructo 1-kinase. Mol. Cell. Biochem. 2004, 266:191-198.
11. Ripoli M., D'Aprile A., Quarato G., Sarasin-Filipowicz M., Gouttenoire J., Scrima R., Cela O., Boffoli D., Heim M.H., Moradpour D., Capitanio N., Piccoli C. Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. J. Virol. 2010, 84:647-660.
12. Pelicano H., Martin D.S., Xu R.H., Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646.
13. Yeung S.J., Pan J., Lee M.H. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell. Mol. Life Sci. 2008, 65:3981-3999.
14. Annibaldi A., Widmann C. Glucose metabolism in cancer cells. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:466-470.
15. Kellenberger L.D., Bruin J.E., Greenaway J., Campbell N.E., Moorehead R.A., Holloway A.C., Petrik J. The role of dysregulated glucose metabolism in epithelial ovarian cancer. J. Oncol. 2010, 2010:514310.
16. Seo E., Park E.J., Park M.K., Kim D.K., Lee H.J., Hong S.H. Differential expression of metabolism-related genes in liver of diabetic obese rats. Korean J. Physiol. Pharmacol. 2010, 14:99-103.
17. Jose C., Bellance N., Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?. Biochim. Biophys. Acta 2011, 1807:552-561.
18. Olefsky J.M. Insulin-stimulated glucose transport minireview series. J. Biol. Chem. 1999, 274:1863.
19. Shepherd P.R., Kahn B.B. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 1999, 341:248-257.
20. Zierler K. Whole body glucose metabolism. Am. J. Physiol. 1999, 276:E409-E426.
21. Vora S., Halper J.P., Knowles D.M. Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy. Cancer Res. 1985, 45:2993-3001.
22. Luther M.A., Cai G.Z., Lee J.C. Thermodynamics of dimer and tetramer formations in rabbit muscle phosphofructokinase. Biochemistry 1986, 25:7931-7937.
23. Roche E., Assimacopoulos-Jeannet F., Witters L.A., Perruchoud B., Yaney G., Corkey B., Asfari M., Prentki M. Induction by glucose of genes coding for glycolytic enzymes in a pancreatic beta-cell line. J. Biol. Chem. 1997, 272:3091-3098.
24. Cai G.Z., Callaci T.P., Luther M.A., Lee J.C. Regulation of rabbit muscle phosphofructokinase by phosphorylation. Biophys. Chem. 1997, 64:199-209.
25. Jiang G., Zhang B.B. Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E671-E678.
26. Zancan P., Marinho-Carvalho M.M., Faber-Barata J., Dellias J.M., Sola-Penna M. ATP and fructose-2,6-bisphosphate regulate skeletal muscle 6-phosphofructo-1-kinase by altering its quaternary structure. IUBMB Life 2008, 60:526-533.
27. Zancan P., Sola-Penna M., Furtado C.M., Da Silva D. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol. Genet. Metab. 2010, 100:372-378.
28. Gomes Alves G., Sola-Penna M. Epinephrine modulates cellular distribution of muscle phosphofructokinase. Mol. Genet. Metab. 2003, 78:302-306.
29. Coelho W.S., Costa K.C., Sola-Penna M. Serotonin stimulates mouse skeletal muscle 6-phosphofructo-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization. Mol. Genet. Metab. 2007, 92:364-370.
30. Real-Hohn A., Zancan P., Da Silva D., Martins E.R., Salgado L.T., Mermelstein C.S., Gomes A.M., Sola-Penna M. Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes. Biochimie 2010, 92:538-544.
31. Yu Y., Maguire T.G., Alwine J.C. Human cytomegalovirus activates glucose transporter 4 expression to increase glucose uptake during infection. J. Virol. 2011, 85:1573-1580.
32. Munger J., Bajad S.U., Coller H.A., Shenk T., Rabinowitz J.D. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006, 2:e132.
33. McArdle J., Schafer X.L., Munger J. Inhibition of calmodulin-dependent kinase kinase blocks human cytomegalovirus-induced glycolytic activation and severely attenuates production of viral progeny. J. Virol. 2011, 85:705-714.
34. Blough H.A., Giuntoli R.L. Successful treatment of human genital herpes infections with 2-deoxy-d-glucose. JAMA 1979, 241:2798-2801.
35. Terekhina N.A., Petrovich Iu A., Parkhomenko T.G. Glycolytic metabolites and adenosine triphosphoric acid in the herpes-infected eye. Zh. Mikrobiol. Epidemiol. Immunobiol. 1998, 92-94.
36. Yu Y., Clippinger A.J., Alwine J.C. Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol. 2011, 19:360-367.
37. Esquenazi D., Wigg M.D., Miranda M.M., Rodrigues H.M., Tostes J.B., Rozental S., da Silva A.J., Alviano C.S. Antimicrobial and antiviral activities of polyphenolics from Cocos nucifera Linn. (Palmae) husk fiber extract. Res. Microbiol. 2002, 153:647-652.
38. Kuo Y.C., Chen C.C., Tsai W.J., Ho Y.H. Regulation of herpes simplex virus type 1 replication in Vero cells by Psychotria serpens: relationship to gene expression, DNA replication, and protein synthesis. Antiviral Res. 2001, 51:95-109.
39. De Logu A., Loy G., Pellerano M.L., Bonsignore L., Schivo M.L. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res. 2000, 48:177-185.
40. Gong Y., Matthews B., Cheung D., Tam T., Gadawski I., Leung D., Holan G., Raff J., Sacks S. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication. Antiviral Res. 2002, 55:319-329.
41. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
42. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89:271-277.
43. Pereira da Silva A.P., El-Bacha T., Kyaw N., dos Santos R.S., da-Silva W.S., Almeida F.C., Da Poian A.T., Galina A. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem. J. 2009, 417:717-726.
44. Wishart D.S., Tzur D., Knox C., Eisner R., Guo A.C., Young N., Cheng D., Jewell K., Arndt D., Sawhney S., Fung C., Nikolai L., Lewis M., Coutouly M.A., Forsythe I., Tang P., Shrivastava S., Jeroncic K., Stothard P., Amegbey G., Block D., Hau D.D., Wagner J., Miniaci J., Clements M., Gebremedhin M., Guo N., Zhang Y., Duggan G.E., Macinnis G.D., Weljie A.M., Dowlatabadi R., Bamforth F., Clive D., Greiner R., Li L., Marrie T., Sykes B.D., Vogel H.J., Querengesser L. HMDB: the human metabolome database. Nucleic Acids Res. 2007, 35:D521-D526.
45. Roizman B.S., A.E. Herpes simplex viruses and their replication. Fields Virolog 1996, vol. 2:2231-2295. Lippincott-Raven Publisher, Philadephia. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
46. Petiot E., Guedon E., Blanchard F., Geny C., Pinton H., Marc A. Kinetic characterization of vero cell metabolism in a serum-free batch culture process. Biotechnol. Bioeng. 2010, 107:143-153.
47. Yang N.C., Ho W.M., Chen Y.H., Hu M.L. A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. Anal. Biochem. 2002, 306:323-327.
48. Sola-Penna M., dos Santos A.C., Alves G.G., El-Bacha T., Faber-Barata J., Pereira M.F., Serejo F.C., Da Poian A.T., Sorenson M. A radioassay for phosphofructokinase-1 activity in cell extracts and purified enzyme. J. Biochem. Biophys. Methods 2002, 50:129-140.
49. Souza T.M., Abrantes J.L., Epifanio R.de A., Leite Fontes C.F., Frugulhetti I.C. The alkaloid 4-methylaaptamine isolated from the sponge Aaptos aaptos impairs herpes simplex virus type 1 penetration and immediate-early protein synthesis. Planta Med. 2007, 73:200-205.
50. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
51. Hussey C.R., Liddle P.F., Ardron D., Kellett G.L. The isolation and characterization of differentially phosphorylated fractions of phosphofructokinase from rabbit skeletal muscle. Eur. J. Biochem. 1977, 80:497-506.
52. Qin J., Chai G., Brewer J.M., Lovelace L.L., Lebioda L. Fluoride inhibition of enolase: crystal structure and thermodynamics. Biochemistry 2006, 45:793-800.
53. Ringrose J.H., Jeeninga R.E., Berkhout B., Speijer D. Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J. Virol. 2008, 82:4320-4330.
54. Sola-Penna M. Metabolic regulation by lactate. IUBMB Life 2008, 60:605-608.
55. Courtney R.J., Steiner S.M., Benyesh-Melnick M. Effects of 2-deoxy-d-glucose on herpes simplex virus replication. Virology 1973, 52:447-455.
56. Radsak K.D., Weder D. Effect of 2-deoxy-d-glucose on cytomegalovirus-induced DNA synthesis in human fibroblasts. J. Gen. Virol. 1981, 57:33-42.
57. Da Silva D., Zancan P., Coelho W.S., Gomez L.S., Sola-Penna M. Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse. Arch. Biochem. Biophys. 2010, 496:53-60.
58. Widnell C.C., Baldwin S.A., Davies A., Martin S., Pasternak C.A. Cellular stress induces a redistribution of the glucose transporter. FASEB J. 1990, 4:1634-1637.
59. Burlandy F.M., Rebello M.A. Inhibition of Mayaro virus replication by prostaglandin A(1) in Vero cells. Intervirology 2001, 44:344-349.
60. Vastag L., Koyuncu E., Grady S.L., Shenk T.E., Rabinowitz J.D. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 2011, 7:e1002124.
61. El-Maghrabi M.R., Claus T.H., Pilkis S.J. Substrate-directed regulation of cAMP-dependent phosphorylation. Methods Enzymol. 1983, 99:212-219.
62. 2+/calmodulin protein kinase. Biochem. Biophys. Res. Commun. 1991, 174:1255-1259.
63. Kemp R.G., Foe L.G. Allosteric regulatory properties of muscle phosphofructokinase. Mol. Cell. Biochem. 1983, 57:147-154.
64. Kamakura M., Nawa A., Ushijima Y., Goshima F., Kawaguchi Y., Kikkawa F., Nishiyama Y. Microarray analysis of transcriptional responses to infection by herpes simplex virus types 1 and 2 and their US3-deficient mutants. Microbes Infect. 2008, 10:405-413.
65. Munger J., Bennett B.D., Parikh A., Feng X.J., McArdle J., Rabitz H.A., Shenk T., Rabinowitz J.D. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 2008, 26:1179-1186.
66. Rolfe D.F., Brown G.C. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol. Rev. 1997, 77:731-758.
67. Baggetto L.G. Deviant energetic metabolism of glycolytic cancer cells. Biochimie 1992, 74:959-974.
68. Sanchez-Martinez C., Aragon J.J. Analysis of phosphofructokinase subunits and isozymes in ascites tumor cells and its original tissue, murine mammary gland. FEBS Lett. 1997, 409:86-90.
69. Meira D.D., Marinho-Carvalho M.M., Teixeira C.A., Veiga V.F., Da Poian A.T., Holandino C., de Freitas M.S., Sola-Penna M. Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. Mol. Genet. Metab. 2005, 84:354-362.